Dr Reddy’s top hand Alok Sonig quits

Alok Sonig, the CEO of developed markets at Dr Reddy’s Laboratories, has quit barely five months after he was promoted to the role. Sonig’s unexpected departure is seen as a setback for Dr Reddy’s, with peers describing him as a man for all seasons. Sonig handled challenging roles during his six-year tenure at the company founded and named after scientist-entrepreneur late K Anji Reddy.

“We confirm that Alok Sonig, CEO – Developed Markets, will be leaving the organisation, effective September 7, 2018,” a Dr Reddy’s spokesperson said in a statement. “The company appreciates his contributions over the past six years and wishes him success in his future endeavours.” Sonig’s exit comes at a critical time, as Dr Reddy’s, much in line with its Indian peers, focuses on a band of specialty and proprietary drugs in the US.

Meanwhile, news reports suggest Dr Reddy’s recently trimmed staff across departments. Sources told ET the move resulted in 75 to 80 job losses.

  • Related Posts

    • Pharma
    • July 24, 2025
    • 266 views
    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

    • Pharma
    • July 22, 2025
    • 329 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra